Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 395

1.

Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia.

Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2001 Oct;251(5):217-24.

PMID:
11829208
[PubMed - indexed for MEDLINE]
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
[PubMed - indexed for MEDLINE]
3.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
[PubMed - indexed for MEDLINE]
4.

Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.

Danion JM, Rein W, Fleurot O.

Am J Psychiatry. 1999 Apr;156(4):610-6.

PMID:
10200742
[PubMed - indexed for MEDLINE]
5.

Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.

Colonna L, Saleem P, Dondey-Nouvel L, Rein W.

Int Clin Psychopharmacol. 2000 Jan;15(1):13-22.

PMID:
10836281
[PubMed - indexed for MEDLINE]
6.

One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistent negative symptoms. Amisulpride v. haloperidol.

Speller JC, Barnes TR, Curson DA, Pantelis C, Alberts JL.

Br J Psychiatry. 1997 Dec;171:564-8.

PMID:
9519098
[PubMed - indexed for MEDLINE]
7.

Amisulpride: progress and outcomes.

Lecrubier Y.

Curr Med Res Opin. 2002;18 Suppl 3:s18-22. Review.

PMID:
12418608
[PubMed - indexed for MEDLINE]
8.

[Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].

Chabannes JP, Pelissolo A, Farah S, Gerard D.

Encephale. 1998 Jul-Aug;24(4):386-92. French.

PMID:
9809244
[PubMed - indexed for MEDLINE]
9.

Clinical update on amisulpride in deficit schizophrenia.

Rein W, Turjanski S.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S19-27. Review.

PMID:
9218164
[PubMed - indexed for MEDLINE]
10.

[Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].

Pélissolo A, Krebs MO, Olié JP.

Encephale. 1996 May-Jun;22(3):215-9. Review. French.

PMID:
8767050
[PubMed - indexed for MEDLINE]
11.

The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.

Lecrubier Y, Quintin P, Bouhassira M, Perrin E, Lancrenon S.

Acta Psychiatr Scand. 2006 Nov;114(5):319-27.

PMID:
17022791
[PubMed - indexed for MEDLINE]
12.

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

Olié JP, Spina E, Murray S, Yang R.

Int Clin Psychopharmacol. 2006 May;21(3):143-51.

PMID:
16528136
[PubMed - indexed for MEDLINE]
13.

Clinical advantages of amisulpride in the treatment of acute schizophrenia.

Burns T, Bale R.

J Int Med Res. 2001 Nov-Dec;29(6):451-66.

PMID:
11803729
[PubMed - indexed for MEDLINE]
14.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
[PubMed - indexed for MEDLINE]
15.

A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.

Riedel M, Eich FX, Möller HJ.

Eur Psychiatry. 2009 Apr;24(3):149-53. doi: 10.1016/j.eurpsy.2008.10.005. Epub 2008 Dec 13.

PMID:
19070995
[PubMed - indexed for MEDLINE]
16.

Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.

Delcker A, Schoon ML, Oczkowski B, Gaertner HJ.

Pharmacopsychiatry. 1990 May;23(3):125-30.

PMID:
1973843
[PubMed - indexed for MEDLINE]
17.

Safety of amisulpride (Solian): a review of 11 clinical studies.

Coulouvrat C, Dondey-Nouvel L.

Int Clin Psychopharmacol. 1999 Jul;14(4):209-18.

PMID:
10468313
[PubMed - indexed for MEDLINE]
18.

Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.

Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O; Amisulpride Study Group.

J Clin Psychopharmacol. 2002 Dec;22(6):554-60.

PMID:
12454554
[PubMed - indexed for MEDLINE]
19.

Safety profile of amisulpride in short- and long-term use.

Rein W, Coulouvrat C, Dondey-Nouvel L.

Acta Psychiatr Scand Suppl. 2000;400:23-7. Review.

PMID:
10823308
[PubMed - indexed for MEDLINE]
20.

Amisulpride: a review of its efficacy in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 2000;400:17-22. Review.

PMID:
10823307
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk